1. Home
  2. PROK vs KVHI Comparison

PROK vs KVHI Comparison

Compare PROK & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • KVHI
  • Stock Information
  • Founded
  • PROK 2015
  • KVHI 1978
  • Country
  • PROK United States
  • KVHI United States
  • Employees
  • PROK N/A
  • KVHI N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PROK Health Care
  • KVHI Technology
  • Exchange
  • PROK Nasdaq
  • KVHI Nasdaq
  • Market Cap
  • PROK 126.8M
  • KVHI 105.7M
  • IPO Year
  • PROK N/A
  • KVHI 1996
  • Fundamental
  • Price
  • PROK $0.60
  • KVHI $5.06
  • Analyst Decision
  • PROK Buy
  • KVHI
  • Analyst Count
  • PROK 4
  • KVHI 0
  • Target Price
  • PROK $5.00
  • KVHI N/A
  • AVG Volume (30 Days)
  • PROK 410.9K
  • KVHI 29.9K
  • Earning Date
  • PROK 05-09-2025
  • KVHI 05-05-2025
  • Dividend Yield
  • PROK N/A
  • KVHI N/A
  • EPS Growth
  • PROK N/A
  • KVHI N/A
  • EPS
  • PROK N/A
  • KVHI N/A
  • Revenue
  • PROK $76,000.00
  • KVHI $113,828,000.00
  • Revenue This Year
  • PROK N/A
  • KVHI N/A
  • Revenue Next Year
  • PROK N/A
  • KVHI N/A
  • P/E Ratio
  • PROK N/A
  • KVHI N/A
  • Revenue Growth
  • PROK N/A
  • KVHI N/A
  • 52 Week Low
  • PROK $0.68
  • KVHI $4.17
  • 52 Week High
  • PROK $4.44
  • KVHI $6.16
  • Technical
  • Relative Strength Index (RSI)
  • PROK 21.04
  • KVHI 43.63
  • Support Level
  • PROK $0.87
  • KVHI $5.13
  • Resistance Level
  • PROK $1.00
  • KVHI $5.74
  • Average True Range (ATR)
  • PROK 0.10
  • KVHI 0.27
  • MACD
  • PROK -0.01
  • KVHI 0.02
  • Stochastic Oscillator
  • PROK 3.98
  • KVHI 39.13

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About KVHI KVH Industries Inc.

KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.

Share on Social Networks: